$10.00
1.0311.48%
Pre-Market: 4:26 PM EDT
Comments
Loading...
GH Research (GHRS) Forecast
NewsEarningsGH Research (GHRS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGH Research (NASDAQ:GHRS) Stock Quotes, Forecast and News Summary
GH Research Stock (NASDAQ: GHRS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GH Research (GHRS) stock?
You can purchase shares of GH Research (NASDAQ:GHRS) through any online brokerage.
Who are GH Research (GHRS) competitors?
Other companies in GH Research’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for GH Research (GHRS) stock?
GH Research has a consensus price target of $41.80.
What is the current price for GH Research (GHRS)?
The stock price for GH Research (NASDAQ: GHRS) is $10 last updated November 14, 2024 at 4:26 PM EST.
Does GH Research (GHRS) pay a dividend?
There are no upcoming dividends for GH Research.
When is GH Research (NASDAQ:GHRS) reporting earnings?
GH Research’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is GH Research (GHRS) going to split?
There is no upcoming split for GH Research.
What sector and industry does GH Research (GHRS) operate in?
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.